Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-026388
Filing Date
2025-09-03
Accepted
2025-09-03 16:05:25
Documents
1
Period of Report
2025-08-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3513
  Complete submission text file 0001641172-25-026388.txt   5055
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 1200 BRICKELL AVENUE SUITE 1950 #1183 MIAMI FL 33131 813-369-5150
MIRA PHARMACEUTICALS, INC. (Issuer) CIK: 0001904286 (see all company filings)

EIN.: 853354547 | State of Incorp.: FL
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173
Business Address
Aminov Erez (Reporting) CIK: 0001986112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41765 | Film No.: 251289672